Clinical Trial Update: (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas

View source ↗

Summary

A clinical trial evaluating the PET tracer 11C-dLop as a marker of P-glycoprotein function in gliomas was terminated. The study enrolled patients with various g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma
• Low-grade Glioma
• Oligoastrocytoma

Drugs mentioned

• (11C)dLop

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Low Grade Glioma, Glioblastoma Multiforme | Status: TERMINATED